Allergen immunotherapy in China

Yaqi Yang; Wenjing Li; Rongfei Zhu; Rongfei Zhu

doi:10.3389/falgy.2023.1324844

Frontiers in Allergy (Jan 2024)

Allergen immunotherapy in China

Yaqi Yang,
Wenjing Li,
Rongfei Zhu,
Rongfei Zhu

Affiliations

Yaqi Yang: Department of Allergy, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
Wenjing Li: Department of Allergy, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
Rongfei Zhu: Department of Allergy, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
Rongfei Zhu: Institute of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China

DOI: https://doi.org/10.3389/falgy.2023.1324844
Journal volume & issue: Vol. 4

Abstract

Read online

Allergen immunotherapy (AIT) is an etiological treatment strategy that involves administering escalating doses of clinically relevant allergens to desensitize the immune system. It has shown encouraging results in reducing allergy symptoms and enhancing patients' quality of life. In this review, we offer a thorough overview of AIT in China, examining its efficacy, safety, current practices, and prospects. We further underscore the progress made in AIT research and clinical applications, as well as the distinct challenges and opportunities that China faces in this area.

Published in Frontiers in Allergy

ISSN: 2673-6101 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: https://www.frontiersin.org/journals/allergy

About the journal

Abstract

Keywords